Replies to post #220287 on Avid Bioservices Inc (CDMO)

[pphmtoolong]

I remember the enthusiasm mounting back in 2012 as we waited and waited and waited for the survival data from the Bavi 2nd Line NSCLC Phase II trial. Sure enough when the data finally did emerge it was great.

As our wait for the first Sunrise look-in drags on, I like to think we will have great news like that from the Phase II, only this time without the CSM screw up.

Every day without the look-in data increases my optimism. Of course, the impatient types just keep dumping their shares. Maybe they will have reason to rue that call.

GLTA, Paul